CONMED Corp. Stock
Price
Target price
€33.60
€33.60
-1.750%
-0.6
-1.750%
€59.49
23.12.25 / Frankfurt
WKN: 886793 / Symbol: CNMD / Name: CONMED / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
CONMED Corp. Stock
We can see a decrease in the price for CONMED Corp.. Compared to yesterday it has lost -€0.600 (-1.750%).
Currently there is a rather positive sentiment for CONMED Corp. with 5 Buy predictions and 0 Sell predictions.
With a target price of 59 € there is a hugely positive potential of 75.6% for CONMED Corp. compared to the current price of 33.6 €.
Pros and Cons of CONMED Corp. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CONMED Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CONMED Corp. | -1.750% | -1.754% | -10.638% | -48.702% | -49.851% | -59.024% | -63.077% |
| Neogen Corp. | -1.640% | -4.688% | 16.190% | -47.414% | -49.167% | - | - |
| Glaukos Corp | -7.500% | 2.062% | 8.791% | -31.724% | -29.787% | 150.000% | 60.976% |
| Penumbra Inc | -1.180% | -0.335% | 5.313% | 16.297% | 17.782% | 27.429% | 70.446% |
Comments
CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Corporation (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $80.00 to $68.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Needham & Company LLC from $91.00 to $61.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
